BioNTech SE (BNTX) Cash from Operations (2018 - 2025)

BioNTech SE has disclosed Cash from Operations across 8 years of filings, most recently posting 360271467.8 for Q4 2025.

• Cash from Operations for Q4 2025 came in at 360271467.8, up 172.77% year-over-year; the trailing twelve-month figure through Dec 2025 was 617578689.96 (up 192.86% YoY), and the FY2025 annual result was 515193902.59, up 132.12% from the prior year.
• Cash from Operations came in at 360271467.8 for Q4 2025 at BioNTech SE, down from 912681309.82 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 4818442194.59 in Q3 2022 to a low of 821206181.94 in Q1 2025.
• The 5-year median for Cash from Operations is 603130291.55 (2022), against an average of 1159382522.17.
• Across the five-year window, Cash from Operations soared 1210566204.64% in 2022 and slumped 179.46% in 2024, its largest moves.
• BioNTech SE's Cash from Operations stood at 228222204.75 in 2021, then soared by 270.69% to 845989115.3 in 2022, then rose by 8.22% to 915517268.55 in 2023, then slumped by 154.08% to 495080248.9 in 2024, then surged by 172.77% to 360271467.8 in 2025.
• The last three Cash from Operations figures came in at 360271467.8 (Q4 2025), 912681309.82 (Q3 2025), and 165832094.29 (Q2 2025), per Business Quant data.